交通医学
交通醫學
교통의학
MEDICAL JOURNAL OF COMMUNICATIONS
2014年
3期
218-220,224
,共4页
许一鸣%仲崇俊%田婷%肖平
許一鳴%仲崇俊%田婷%肖平
허일명%중숭준%전정%초평
食管鳞癌%微小RNA%let-7e%实时荧光定量聚合酶链反应
食管鱗癌%微小RNA%let-7e%實時熒光定量聚閤酶鏈反應
식관린암%미소RNA%let-7e%실시형광정량취합매련반응
esophageal squamous cell cancer%MicroRNA%let-7e%real-time florescent quanlititive polymerase chain reaction
目的:检测食管鳞癌患者不同临床分期癌组织及癌旁组织中MicroRNA let-7e表达水平的差异。方法:应用实时荧光定量RT-PCR Taqman MGB探针法,检测60例食管癌癌组织及癌旁组织中MicroRNA let-7e表达水平。以U6 snRNA为内参,进行荧光定量PCR,统计分析表达水平的差异。结果:MicroRNA let-7e的表达水平在癌组织比癌旁组织高,病理分期I期与III期相比,差异有统计学意义(P<0.05)。结论:MicroRNA let-7e在食管鳞癌中表达水平明显高于癌旁组织,可能用于食管鳞癌临床分期诊断的重要标记。
目的:檢測食管鱗癌患者不同臨床分期癌組織及癌徬組織中MicroRNA let-7e錶達水平的差異。方法:應用實時熒光定量RT-PCR Taqman MGB探針法,檢測60例食管癌癌組織及癌徬組織中MicroRNA let-7e錶達水平。以U6 snRNA為內參,進行熒光定量PCR,統計分析錶達水平的差異。結果:MicroRNA let-7e的錶達水平在癌組織比癌徬組織高,病理分期I期與III期相比,差異有統計學意義(P<0.05)。結論:MicroRNA let-7e在食管鱗癌中錶達水平明顯高于癌徬組織,可能用于食管鱗癌臨床分期診斷的重要標記。
목적:검측식관린암환자불동림상분기암조직급암방조직중MicroRNA let-7e표체수평적차이。방법:응용실시형광정량RT-PCR Taqman MGB탐침법,검측60례식관암암조직급암방조직중MicroRNA let-7e표체수평。이U6 snRNA위내삼,진행형광정량PCR,통계분석표체수평적차이。결과:MicroRNA let-7e적표체수평재암조직비암방조직고,병리분기I기여III기상비,차이유통계학의의(P<0.05)。결론:MicroRNA let-7e재식관린암중표체수평명현고우암방조직,가능용우식관린암림상분기진단적중요표기。
Purpose: To investigate the expression levels of MicroRNA let-7e in esophageal squamous cell cancer patients and to compare cancer tissues with adjacent normal lung tissues in different clinical stages. Method: The MicroR-NA let-7e expression levels in cancer tissues and adjacent normal lung tissues were detected by quantitative real-time re-verse transcription-PCR from 60 esophageal squamous cell cancer patients who were divided into three groups, with U6 RNA as an actin. Results: The expression levels of MicroRNA let-7e in cancer tissues were significantly higher than in adjacent normal esophageal tissues, and had statistical significance in different stages of the tumors: characteristics, lymph metastasis, differentiation, and the stage of the tumors. Conclusions: The study suggested that microRNA let-7e was sig-nificantly up-expressed in esophageal squmaos cell cancer and should be a useful biomarker for the diagnosis of clinical stages of esophageal cancer patients.